Ovarian carcinoma (OC) is one of the leading causes of death among gynecologic
malignancies all over the world. It is characterized by high mortality rate because of the lack …

Background Ovarian cancer is the most leading cause of death and the third most common
gynecologic malignancy in women. Traditional chemotherapy has inevitable drawbacks of …

In this paper, an overview of recent advances of paclitaxel formulations based on
nanosystems is provided. Paclitaxel is very effective in the treatment of various cancers …

Paclitaxel is one of the most effective chemotherapeutic drugs which processes the obvious
curative effect for a broad range of cancers including breast, ovarian, lung, and head & neck …

Paclitaxel (PTX) is an effective anticancer chemical with a broad spectrum that was primarily
obtained from a curative shrub, specifically the bark of Taxus brevifolia tree. It belongs to a …

Paclitaxel is one of the most effective chemotherapeutic drugs ever developed and is active
against a broad range of cancers, such as lung, ovarian, and breast cancers. Due to its low …

Adenocarcinoma is the most lethal gynecologic tumor and treatment usually consists in
surgery followed by chemotherapy. However, the chemotherapy benefits are eventually …

Cancer cases have reached an all-time high in the current era. Thus, there is a need to
develop advanced therapeutic methods that can effectively inhibit the proliferation of …

In recent years, the nanotechnology has offered researchers the opportunity to solve the
problems caused by the vehicle of the standard and first formulation of paclitaxel (Taxol®) …

Ovarian cancer is the leading cause of death from gynecological malignancies worldwide.
Although the majority of tumors initially respond to standard treatments combining surgery …